Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction.
about
Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathyIntra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune toleranceAnimal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapyGene transfer in skeletal and cardiac muscle using recombinant adeno-associated virusDystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel TherapiesX-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy.Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse.AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9.Progress in gene therapy of dystrophic heart disease.Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.100-fold but not 50-fold dystrophin overexpression aggravates electrocardiographic defects in the mdx model of Duchenne muscular dystrophy.Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy.Enhancement of Satellite Cell Transplantation Efficiency by Leukemia Inhibitory Factor.Prospect for pharmacological therapies to treat skeletal muscle dysfunction.Systemic delivery of adeno-associated viral vectors.Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular DystrophyMicro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/ Mice
P2860
Q27006945-7B166D5C-1172-446A-AEFA-809F0CD3C49AQ27317882-8AFA70CF-B415-42E1-A475-83E21C362520Q28084979-469C0402-98E1-47E3-8BAA-FB6F6189E7CCQ30539495-D362684A-0CBB-4BED-8BEB-680E87A72F7AQ33608478-F17AC6E5-9028-4E28-B79B-544CC5787D0FQ35818371-F7F39D3E-DAE3-4C9D-944A-A48F539EBE99Q35973260-BA82B93C-0EB6-4DD7-8EC9-C1708E7C82E1Q36074749-6C05FC67-0A12-4500-B7D8-C9F7FD37C86FQ36757156-682D968F-B3C5-4801-89C3-05E7302E22E4Q36773242-B288C732-F7AC-4B46-91C8-0F58DB916089Q37021623-5617F261-C9DB-41F3-8E62-D2CCA4A188A2Q37069117-D128075D-F8A7-455A-96F1-B9EE7803A0B4Q37277411-1CED3299-FC65-4AEC-A6A4-7B6CA77C373DQ37610588-3EACA501-0CBA-48F5-964C-847DFD5E25F3Q38264369-D25F5F82-C059-4874-8518-914BFCD87F26Q38908933-6E1408E5-77DD-4039-BF00-BF8F4983C47BQ57039821-2A92E69B-FF14-44B1-A11A-64A6B9C5B02DQ58730294-10360429-11AE-4E55-8A03-1659518B466C
P2860
Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Improvement of cardiac fibrosi ...... microdystrophin transduction.
@en
Improvement of cardiac fibrosi ...... microdystrophin transduction.
@nl
type
label
Improvement of cardiac fibrosi ...... microdystrophin transduction.
@en
Improvement of cardiac fibrosi ...... microdystrophin transduction.
@nl
prefLabel
Improvement of cardiac fibrosi ...... microdystrophin transduction.
@en
Improvement of cardiac fibrosi ...... microdystrophin transduction.
@nl
P2093
P2860
P356
P1433
P1476
Improvement of cardiac fibrosi ...... d microdystrophin transduction
@en
P2093
K Kinoshita
S Ohshima-Hosoyama
Y Nitahara-Kasahara
P2860
P2888
P304
P356
10.1038/GT.2011.36
P50
P577
2011-03-31T00:00:00Z
P5875
P6179
1053241020